Date of Award


Document Type


Degree Name

Master of Physician Assistant Studies


Physician Assistant Education

First Advisor

Rahnea Sunseri


Patients with chronic obstructive pulmonary disease (COPD) have high rates of cardiovascular comorbidities, including hypertension, ischemic heart disease, and heart failure. These comorbidities further complicate management of COPD patients. Cardiovascular complications are especially difficult to manage during acute exacerbations of chronic obstructive pulmonary disease (AECOPD). Multiple factors are contributory, including hypoxemia, tachycardia, increased inflammation, and arterial stiffness. Cardioselective beta-blockers have been proven to be safe and effective in managing cardiovascular conditions such as heart failure and arrhythmias and are recommended for acutely decompensated heart failure and myocardial infarction in the setting of AECOPD. Benefits include reducing all-cause mortality and the risk of COPD exacerbations.1 However, beta-blockers continue to be underused in COPD patients due to lingering concerns about bronchospasm leading to exacerbation of COPD symptoms requiring hospitalization. Whether the use of beta-blockers for cardiovascular disease in patients with COPD would decrease pulmonary function or increase frequency of exacerbations, hospitalizations, and mortality will be examined.

Kang_Presentation Slides.pptx (1040 kB)
Click here to download Presentation Slides

Kang_Presentation Slides.pptx (1040 kB)
Click here to download Presentation Slides



To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.